Ranbaxy Posts FQ4 Loss

by Lisa Levin, Benzinga Editor
February 26, 2013 6:24 AM | 16 seconds read |
India's Ranbaxy Laboratories RBXZF reported a loss in the fiscal fourth quarter. Ranbaxy posted a quarterly loss of 4.92 billion rupees ($91.30 million). However, analysts were expecting a consolidated net profit of 1.44 billion rupees. Its consolidated sales dropped 28.8% to 26.71 billion rupees in the quarter.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: EarningsNewsloss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!